Jan 11 (Reuters) - Baxalta Inc and Coherus Biosciences Inc said their experimental biosimilar of Amgen Inc's arthritis drug Enbrel met the main goal in a late-stage study.
The drug, CHS-0214, was found to be as effective as Enbrel in rheumatoid arthritis patients, the companies said.
(Reporting by Amrutha Penumudi in Bengaluru; Editing by Ted Kerr)
Futures fell on reports of Iran explosions: The market power trend is about to end. Netflix gave weak guidance.
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Netflix reported first quarter earnings after the bell on Thursday. Here's what to know.
The insurer was accused by a short-seller of "extensive" fraud.
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
An FAQ on the Truth Social owner’s website gave stockholders multiple ways to avoid their shares being lent to short sellers.
These members of Congress delivered greater returns than Warren Buffett in 2023.